For: | Manrai M, Tilak TVSVGK, Dawra S, Srivastava S, Singh A. Current and emerging therapeutic strategies in pancreatic cancer: Challenges and opportunities. World J Gastroenterol 2021; 27(39): 6572-6589 [PMID: 34754153 DOI: 10.3748/wjg.v27.i39.6572] |
---|---|
URL: | https://www.wjgnet.com/2218-4333/full/v27/i39/6572.htm |
Number | Citing Articles |
1 |
Qiu-Yu Jiang, Zhi-Xue Chen, Si Zhang, Ru-Yi Xue. Future therapies for pancreatic carcinoma: Insights into cancer precision medicine. World Journal of Gastroenterology 2022; 28(22): 2523-2526 doi: 10.3748/wjg.v28.i22.2523
Abstract(689) |
Core Tip(530) |
Full Article(HTML)(2496)
|
Full Article (PDF)-1889K(280)
|
Full Article (Word)-106K(84)
|
Audio-426K(3)
|
Peer-Review Report-226K(95)
|
Answering Reviewers-111K(85)
|
Times Cited (0)
|
Total Visits (6029)
|
Open
|
2 |
Yuvasri Golivi, Seema Kumari, Batoul Farran, Afroz Alam, Sujatha Peela, Ganji Purnachandra Nagaraju. Small molecular inhibitors: Therapeutic strategies for pancreatic cancer. Drug Discovery Today 2024; 29(7): 104053 doi: 10.1016/j.drudis.2024.104053
|
3 |
Shilong Han, Chuanwu Cao, Rui Liu, YiFeng Yuan, Long Pan, Minjie Xu, Chao Hu, Xiaojun Zhang, Maoquan Li, Xiaoping Zhang. GAS41 mediates proliferation and GEM chemoresistance via H2A.Z.2 and Notch1 in pancreatic cancer. Cellular Oncology 2022; 45(3): 429 doi: 10.1007/s13402-022-00675-8
|
4 |
Raoof Nopour. Prediction of 12-month recurrence of pancreatic cancer using machine learning and prognostic factors. BMC Medical Informatics and Decision Making 2024; 24(1) doi: 10.1186/s12911-024-02766-y
|
5 |
Yasuo Otsuka, Ken Kamata, Masatoshi Kudo. Contrast-Enhanced Harmonic Endoscopic Ultrasound-Guided Puncture for the Patients with Pancreatic Masses. Diagnostics 2023; 13(6): 1039 doi: 10.3390/diagnostics13061039
|
6 |
Jiajing Li, Hongfei Zhang, Qian Du, Junyu Gu, Jiangbo Wu, Qi Liu, Zhuo Li, Ting Zhang, Jingyu Xu, Rui Xie. Research Progress on TRPA1 in Diseases. The Journal of Membrane Biology 2023; 256(4-6): 301 doi: 10.1007/s00232-023-00277-x
|
7 |
Yanyan Da, Yuxia Liu, Yuan Hu, Wenzeng Liu, Junpeng Ma, Nan Lu, Chengsheng Zhang, Cai Zhang. STING agonist cGAMP enhances anti-tumor activity of CAR-NK cells against pancreatic cancer. OncoImmunology 2022; 11(1) doi: 10.1080/2162402X.2022.2054105
|
8 |
Jun Zhu, Yanlong Shi, Sheng Lan, Jingyan Wang, Fei Jiang, Caiping Tang, Yuan Cai, Ziyuan Pan, Haokun Jian, Hanlu Fang, Yewei Zhang, Fei Zhong. Dissection of pyroptosis-related prognostic signature and CASP6-mediated regulation in pancreatic adenocarcinoma: new sights to clinical decision-making. Apoptosis 2023; 28(5-6): 769 doi: 10.1007/s10495-023-01823-7
|
9 |
Jindan Qi, Mei Meng, Juntao Liu, Xiaoxiao Song, Yu Chen, Yuxi Liu, Xu Li, Zhou Zhou, Xiang Huang, Xiaohua Wang, Quansheng Zhou, Zhe Zhao. Lycorine inhibits pancreatic cancer cell growth and neovascularization by inducing Notch1 degradation and downregulating key vasculogenic genes. Biochemical Pharmacology 2023; 217: 115833 doi: 10.1016/j.bcp.2023.115833
|
10 |
Jing Wang, Yiyu Shen, Xiaoguang Wang, Zhongcheng Zhou, Zhengxiang Zhong, Tianyuan Gu, Bin Wu. Long non-coding RNA AL137789.1 promoted malignant biological behaviors and immune escape of pancreatic carcinoma cells. Open Medicine 2023; 18(1) doi: 10.1515/med-2023-0661
|
11 |
Oluwabukunmi Olajubutu, Omotola D. Ogundipe, Amusa Adebayo, Simeon K. Adesina. Drug Delivery Strategies for the Treatment of Pancreatic Cancer. Pharmaceutics 2023; 15(5): 1318 doi: 10.3390/pharmaceutics15051318
|
12 |
Alessandra Barbanente, Joanna Kopecka, Daniele Vitone, Mauro Niso, Rosanna Rizzi, Corrado Cuocci, Francesca Serena Abatematteo, Francesco Mastropasqua, Nicola Antonio Colabufo, Nicola Margiotta, Fabio Arnesano, Chiara Riganti, Carmen Abate. First-In-Class Thiosemicarbazone Metal Complexes Targeting the Sigma-2 Receptor (S2R) as an Innovative Strategy against Pancreatic Cancer. Journal of Medicinal Chemistry 2024; doi: 10.1021/acs.jmedchem.4c01410
|
13 |
Xiaoqing Guan, Bing Zhao, Xiaodan Guan, Jinyun Dong, Jieer Ying. A benzochalcone derivative synchronously induces apoptosis and ferroptosis in pancreatic cancer cells. PeerJ 2023; 11: e16291 doi: 10.7717/peerj.16291
|
14 |
Chundong Cheng, Zonglin Liu, Danxi Liu, Hua Chen, Yongwei Wang, Bei Sun. LncRNA CCAT1 participates in pancreatic ductal adenocarcinoma progression by forming a positive feedback loop with c-Myc. Carcinogenesis 2024; 45(1-2): 69 doi: 10.1093/carcin/bgad076
|
15 |
Chinmayee Priyadarsini Dash, Dhruba Sonowal, Prachi Dhaka, Rohit Yadav, Dewan Chettri, Bibhu Prasad Satapathy, Pooja Sheoran, Vivek Uttam, Manju Jain, Aklank Jain. Antitumor activity of genetically engineered NK-cells in non-hematological solid tumor: a comprehensive review. Frontiers in Immunology 2024; 15 doi: 10.3389/fimmu.2024.1390498
|
16 |
Xiang Wu, Shuping Zhou, Luoluo Wang, Jingyun Ma, Yang Zhou, Yi Ruan, Hanjie Shao, Xinhua Zhou, Hong Li. Circ_103809 Aggravates the Malignant Phenotype of Pancreatic Cancer Through Modulating miR-197-3p/TSPAN3 Axis. Molecular Biotechnology 2024; 66(9): 2455 doi: 10.1007/s12033-023-00874-0
|
17 |
媛媛 苏. Effects of Radiotherapy and Chemotherapy on Postoperative Prognosis of Patients Undergoing Radical Surgery for Pancreatic Cancer—Based on SEER Database Analysis. Advances in Clinical Medicine 2022; 12(10): 9540 doi: 10.12677/ACM.2022.12101380
|